NY Judge Dismisses Nabriva Investors' FDA Approval Suit
A Manhattan federal judge on Tuesday threw out a putative class action against Nabriva Therapeutics, ending allegations that the biopharmaceutical company misrepresented its prospects of getting federal approval for a new...To view the full article, register now.
Already a subscriber? Click here to view full article